Aytu Biopharma (AYTU) closed at $1.98 on October 22, 2026, up 1.0% from the previous close, on volume of 25,700 shares (30-day average 42,477).
Data as of October 22, 2026.
No headlines found.
Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results
ACCESS Newswire (Tue, 22-Sep 4:05 PM ET)
ACCESS Newswire (Wed, 16-Sep 4:30 PM ET)
Aytu BioPharma Inc is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. It has single operating segment. Its product portfolio includes EXXUA, ADHD Portfolio, Pediatric Portfolio, and Other. Majority of revenue comes from ADHD Portfolio. It has presence in United States.
Aytu Biopharma trades on the NASDAQ stock market under the symbol AYTU.
As of October 22, 2026, AYTU stock price climbed to $1.98 with 25,700 million shares trading.
AYTU has a beta of 0.78, meaning it tends to be less sensitive to market movements. AYTU has a correlation of 0.05 to the broad based SPY ETF.
AYTU has a market cap of $21.52 million. This is considered a Sub-Micro Cap stock.
Last quarter Aytu Biopharma reported $16 million in Revenue and $.00 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.32.
In the last 3 years, AYTU traded as high as $3.45 and as low as $.95.
The top ETF exchange traded funds that AYTU belongs to (by Net Assets): VTI, VXF, DCOR, DFAC, DXUV.
AYTU has underperformed the market in the last year with a price return of -16.1% while the SPY ETF gained +14.9%. AYTU has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.2% and -3.4%, respectively, while the SPY returned +2.3% and -1.7%, respectively.
AYTU support price is $1.89 and resistance is $2.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AYTU shares will trade within this expected range on the day.
